Skip to main content
Premium Trial:

Request an Annual Quote

Roche Non-Exclusively Licenses Melting Curve Tech to Eppendorf

NEW YORK (GenomeWeb News) - Roche Diagnostics has licensed its Melting Curve Analysis technology to Eppendorf, the companies said Tuesday.
 
The non-exclusive agreement allows Eppendorf to develop and commercialize products based on the technology, which is a technique for analyzing PCR products. The deal does not allow Eppendorf to use the IP in human and veterinary in vitro diagnostics.
 
The Melting Curve Analysis technology identifies DNA and is used after PCR. It involves heating the PCR product slowly until each double-stranded DNA rises to its unique melting temperature.  
 
Financial terms of the agreement were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more